WallStreetZenWallStreetZen

NASDAQ: IMDX
Insight Molecular Diagnostics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Insight Molecular Diagnostics earnings were -$47.8M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest IMDX earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$4.3M, down 81.3% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, IMDX reported annual earnings of -$50.2M, with -17.6% growth. The next IMDX earnings date is Aug 10, 2026.

IMDX earnings history

Current Revenue
$1.9M
Current Earnings
-$47.8M
Current Profit Margin
-2,454.6%

IMDX Return on Equity

Current Company
N/A
Current Industry
-8.9%
Current Market
13.5%

IMDX Return on Assets

Current Company
-119.1%
Current Industry
7%
IMDX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when IMDX announces earnings.

IMDX Return on Capital Employed

Current Company
-167.96%
Current Industry
13.2%
IMDX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

IMDX vs Diagnostic & Research Stocks

TickerEBITDAEarningsY/Y EarningsEPS
IMDX-$45.40M-$47.84MN/A-$1.50
BDSX-$18.30M-$31.96MN/A-$4.00
XGN-$11.77M-$20.17MN/A-$0.89
STIM-$25.06M-$37.11MN/A-$0.54
BNRN/A-$8.74MN/A-$0.84
View Top Diagnostic & Research Stocks

IMDX earnings dates

Next earnings date
Aug 10, 2026

Insight Molecular Diagnostics Earnings Reports & History FAQ

What were Insight Molecular Diagnostics's earnings last quarter?

Insight Molecular Diagnostics (NASDAQ: IMDX) reported Q1 2026 earnings per share (EPS) of -$0.12, up 53.85% year over year. Total IMDX earnings for the quarter were -$4.29 million. In the same quarter last year, Insight Molecular Diagnostics's earnings per share (EPS) was -$0.26.

If you're new to stock investing, here's how to buy Insight Molecular Diagnostics stock.

When does Insight Molecular Diagnostics report earnings?

The next IMDX earnings call is Invalid Date. Add IMDX to your watchlist to be reminded of Insight Molecular Diagnostics's next earnings date.

What was IMDX's earnings growth in the past year?

As of Insight Molecular Diagnostics's earnings date in Q2 2026, Insight Molecular Diagnostics's earnings has grown year over year. IMDX earnings in the past year totalled -$47.84 million.

Is Insight Molecular Diagnostics profitable or losing money?

As of the last Insight Molecular Diagnostics earnings report, Insight Molecular Diagnostics is currently losing money. Insight Molecular Diagnostics's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$47.84 million, a 17.89% decrease year over year.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.